Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery

Clinical trial NCT03923556 · COMPLETED

Trial details

NCT number: NCT03923556
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Kidney Transplant; Complications Postoperative Residual Curarization Postoperative Residual Weakness

Start date: 2021-02-02
Primary completion: 2023-09-30
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.